Listar por autor "Ntzifa A., Londra D., Rampias T., Kotsakis A., Georgoulias V., Lianidou E."
Mostrando ítems 1-1 de 1
-
DNA methylation analysis in plasma cell-free DNA and paired CTCs of NSCLC patients before and after osimertinib treatment
Ntzifa A., Londra D., Rampias T., Kotsakis A., Georgoulias V., Lianidou E. (2021)Osimertinib has been an effective second-line treatment in EGFR mutant NSCLC patients; however, resistance inevitably occurs. DNA methylation has been previously implicated in NSCLC progression and often in therapy resistance, ...